npj Regenerative Medicine

npj Regenerative Medicine is an open access, online-only journal from the Nature Portfolio published in partnership with Monash University, launched in 2016 and dedicated to research that helps the human body repair, replace, restore and regenerate damaged tissues and organs, with a 2025 Journal Impact Factor of 7.0《NPJ 再生医学》（npj Regenerative Medicine）是（Nature Portfolio）与蒙纳士大学合作出版的开放获取纯在线期刊，2016 年创刊，聚焦帮助人体修复、替换、恢复与再生受损组织与器官的研究，2025 年影响因子为 7.0。

Scope

• The journal publishes the highest quality research into ways to help the human body repair, replace, restore and regenerate damaged tissues and organs期刊发表帮助人体修复、替换、恢复与再生受损组织与器官的高质量研究。
• It grew out of tissue engineering and now covers the use of stem cells for disease modelling, autologous transplant and therapeutic delivery of functional molecules该刊由组织工程领域发展而来，现涵盖干细胞用于疾病建模、自体移植与功能分子治疗性递送。
• The production of tissues and organs in a dish is within its remit在培养体系中构建组织与器官属于其收录范围。
• The role of immune function in tissue repair is a distinct area of interest免疫功能在组织修复中的作用是独立的关注领域。
• Biomedical engineering is explicitly named as a burgeoning area of the journal生物医学工程被明确列为该刊快速发展的领域。
• Because regenerative medicine is highly cross-disciplinary, submissions spanning cell biology, engineering and clinical translation are welcomed由于再生医学高度跨学科，涵盖细胞生物学、工程学与临床转化的投稿均受欢迎。

History

• The journal was launched in 2016 as one of the Nature Partner Journals, published by Nature Publishing Group in partnership with Monash University and the Australian Regenerative Medicine Institute该刊 2016 年作为「Nature Partner Journals」之一创刊，由（Nature Publishing Group）与蒙纳士大学及澳大利亚再生医学研究所合作出版。
• Its first article appeared in June 2016 and set out the case for regenerative medicine as a cross-disciplinary field linking stem cells, tissue engineering and biomedical engineering其首篇文章于 2016 年 6 月发表，阐明再生医学作为连接干细胞、组织工程与生物医学工程的跨学科领域的定位。
• The founding editor-in-chief was Nadia Rosenthal, then director of the Australian Regenerative Medicine Institute创刊主编为（Nadia Rosenthal），时任澳大利亚再生医学研究所所长。
• It is published continuously online with a single electronic ISSN 2057-3995 and no print edition该刊以纯在线方式连续出版，仅有电子 ISSN 2057-3995，无纸本版。
• Publication is funded by an article processing charge of up to 3590 euros, 4390 US dollars or 3190 pounds with a waiver policy, under CC BY or CC BY-NC-ND licences出版由最高 3590 欧元、4390 美元或 3190 英镑的文章处理费支持并设有减免政策，采用（CC BY）或（CC BY-NC-ND）许可协议。
• Its Journal Impact Factor moved from 10.364 in 2021 through 14.404 in 2022 and 6.5 in 2024 to 7.0 in 2025其影响因子由 2021 年的 10.364 经 2022 年的 14.404 与 2024 年的 6.5 变为 2025 年的 7.0。

Editors

• The founding editor-in-chief was Nadia Rosenthal of the Australian Regenerative Medicine Institute at Monash University创刊主编为蒙纳士大学澳大利亚再生医学研究所的（Nadia Rosenthal）。
• The editorial board is drawn from the international regenerative medicine community together with the journal's university partner编委会由国际再生医学学界与该刊大学合作伙伴的研究人员组成。
• Submitted manuscripts are subject to anonymous peer review and are checked for plagiarism投稿实行匿名同行评审，并进行重复率检查。
• The journal is indexed in the Science Citation Index Expanded, Scopus and the Directory of Open Access Journals该刊被（Science Citation Index Expanded）、（Scopus）与（Directory of Open Access Journals）收录。
• Accepted articles are free to read immediately on publication, and authors retain the option of a non-commercial no-derivatives licence录用文章发表后即时免费阅读，作者可选择非商业性禁止演绎许可协议。